Cabaletta Bio, Inc. (CABA)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $215k
- Jan 19 · Unusual
- Form 4 sales
- 13
- On record
- Form 144 notices
- 8
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jan 19, 2024Unusual
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$215k11,000 shares at $19.59
- Dec 19, 2023Unusual
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$241k11,000 shares at $21.89
- Nov 20, 2023Unusual
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$196k11,000 shares at $17.82
- Nov 20, 2023Notice
Binder Gwendolyn, President, Science & Tech., filed a notice to sell 33,000 shares
$593k33,000 shares
- Oct 19, 2023Unusual
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$147k11,000 shares at $13.36
- Oct 19, 2023Notice
Binder Gwendolyn, President, Science & Tech., filed a notice to sell 11,000 shares
$148k11,000 shares
- Sep 19, 2023Routine
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$193k11,000 shares at $17.56
- Sep 19, 2023Notice
Binder Gwendolyn, President, Science & Tech., filed a notice to sell 11,000 shares
$205k11,000 shares
- Aug 21, 2023Routine
Binder Gwendolyn, Officer, sold 35.5% of their holdings
$148k11,000 shares at $13.42
- Aug 21, 2023Notice
Binder Gwendolyn, President, Science & Tech., filed a notice to sell 11,000 shares
$139k11,000 shares
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 10, 2026 | CABA | Tomasello Shawn | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | CABA | Simon Mark | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | CABA | Henriques Richard C Jr | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | CABA | Bollard Catherine | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | CABA | Brun Scott C. | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Das Arun | Chief Business Officer | AwardedStock Option (Right to Buy) | 175,000 | 175,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Gerard Michael | General Counsel | AwardedStock Option (Right to Buy) | 175,000 | 175,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Binder Gwendolyn | President, Science & Tech. | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Chang David J. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Nichtberger Steven | President & CEO | AwardedStock Option (Right to Buy) | 674,000 | 674,000 | SEC | ||
| Mar 2, 2026 | Mar 2, 2026 | CABA | Marda Anup | Chief Financial Officer | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Jan 21, 2026 | Jan 21, 2026 | CABA | Chang David J. | Chief Medical Officer | Bought | 8,800 | $2.26 | $20k | 8,800 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Binder Gwendolyn | President, Science & Tech. | Bought | 11,312 | $2.19 | $25k | 31,312 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Tomasello Shawn | Director | Bought | 22,725 | $2.21 | $50k | 22,725 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Gavel Steve | Chief Commercial Officer | Bought | 22,170 | $2.27 | $50k | 22,170 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Bollard Catherine | Director | Bought | 4,405 | $2.27 | $10k | 5,405 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Nichtberger Steven | President & CEO | Bought | 45,000 | $2.24 | $101k | 1M | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Simon Mark | Director | Bought | 11,061 | $2.28 | $25k | 147,205 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | CABA | Gerard Michael | General Counsel | Bought | 6,600 | $2.27 | $15k | 6,600 | SEC |
| Oct 13, 2025 | Oct 15, 2025 | CABA | Gavel Steve | CHIEF COMMERCIAL OFFICER | AwardedStock Option (Right to Buy) | 275,000 | 275,000 | SEC | ||
| Jun 9, 2025 | Jun 9, 2025 | CABA | Simon Mark | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2025 | Jun 9, 2025 | CABA | Brun Scott C. | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2025 | Jun 9, 2025 | CABA | Bollard Catherine | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2025 | Jun 9, 2025 | CABA | Tomasello Shawn | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| Jun 9, 2025 | Jun 9, 2025 | CABA | Henriques Richard C Jr | Director | AwardedStock Option (Right to Buy) | 22,000 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Brun Scott C. | Director | Returned to the companyStock Option (Right to Buy) | 88,000 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Brun Scott C. | Director | AwardedStock Option (Right to Buy) | 88,000 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Nichtberger Steven | President & CEO | Returned to the companyStock Option (Right to Buy) | 1.9M | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Nichtberger Steven | President & CEO | AwardedStock Option (Right to Buy) | 1.9M | 353,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Gerard Michael | General Counsel | Returned to the companyStock Option (Right to Buy) | 387,500 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Gerard Michael | General Counsel | AwardedStock Option (Right to Buy) | 387,500 | 100,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Henriques Richard C Jr | Director | Returned to the companyStock Option (Right to Buy) | 112,428 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Henriques Richard C Jr | Director | AwardedStock Option (Right to Buy) | 112,428 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Tomasello Shawn | Director | Returned to the companyStock Option (Right to Buy) | 66,000 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Tomasello Shawn | Director | AwardedStock Option (Right to Buy) | 66,000 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Marda Anup | Chief Financial Officer | Returned to the companyStock Option (Right to Buy) | 745,456 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Marda Anup | Chief Financial Officer | AwardedStock Option (Right to Buy) | 745,456 | 130,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Simon Mark | Director | Returned to the companyStock Option (Right to Buy) | 84,460 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Simon Mark | Director | AwardedStock Option (Right to Buy) | 84,460 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Binder Gwendolyn | President, Science & Tech. | Returned to the companyStock Option (Right to Buy) | 687,575 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Binder Gwendolyn | President, Science & Tech. | AwardedStock Option (Right to Buy) | 687,575 | 130,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Das Arun | Chief Business Officer | Returned to the companyStock Option (Right to Buy) | 403,416 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Das Arun | Chief Business Officer | AwardedStock Option (Right to Buy) | 403,416 | 100,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Bollard Catherine | Director | Returned to the companyStock Option (Right to Buy) | 112,428 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Bollard Catherine | Director | AwardedStock Option (Right to Buy) | 112,428 | 22,000 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Chang David J. | Chief Medical Officer | Returned to the companyStock Option (Right to Buy) | 801,283 | 0 | SEC | ||
| May 19, 2025 | May 19, 2025 | CABA | Chang David J. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 801,283 | 130,000 | SEC | ||
| Mar 3, 2025 | Mar 4, 2025 | CABA | Binder Gwendolyn | President, Science & Tech. | AwardedStock Option (Right to Buy) | 145,000 | 145,000 | SEC | ||
| Mar 3, 2025 | Mar 4, 2025 | CABA | Marda Anup | Chief Financial Officer | AwardedStock Option (Right to Buy) | 145,000 | 145,000 | SEC | ||
| Mar 3, 2025 | Mar 4, 2025 | CABA | Gerard Michael | General Counsel | AwardedStock Option (Right to Buy) | 115,000 | 115,000 | SEC |
Sales, notices and lockups (21)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Jan 19, 2024 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $215k | 35.5% | Unusual | SEC |
| Dec 19, 2023 | Dec 19, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $241k | 35.5% | Unusual | SEC |
| Nov 20, 2023 | Nov 21, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $196k | 35.5% | Unusual | SEC |
| Nov 20, 2023 | Nov 20, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 33,000 | $593k | Notice | SEC | |
| Oct 19, 2023 | Oct 19, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $147k | 35.5% | Unusual | SEC |
| Oct 19, 2023 | Oct 19, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $148k | Notice | SEC | |
| Sep 19, 2023 | Sep 20, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $193k | 35.5% | Routine | SEC |
| Sep 19, 2023 | Sep 19, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $205k | Notice | SEC | |
| Aug 21, 2023 | Aug 22, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $148k | 35.5% | Routine | SEC |
| Aug 21, 2023 | Aug 21, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $139k | Notice | SEC | |
| Jul 19, 2023 | Jul 19, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $152k | 35.5% | Routine | SEC |
| Jul 19, 2023 | Jul 19, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $154k | Notice | SEC | |
| Jun 20, 2023 | Jun 21, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 11,000 | $143k | 35.5% | Routine | SEC |
| Jun 20, 2023 | Jun 20, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $144k | Notice | SEC | |
| Jun 20, 2023 | Jun 20, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 11,000 | $144k | Notice | SEC | |
| May 19, 2023 | May 19, 2023 | Binder Gwendolyn | CABA | Officer | Form 4 sale | 22,000 | $260k | 52.4% | Routine | SEC |
| May 19, 2023 | May 19, 2023 | Binder Gwendolyn | CABA | President, Science & Tech. | Form 144 notice | 22,000 | $271k | Notice | SEC | |
| Nov 1, 2021 | Nov 3, 2021 | 5AM Partners V, LLC | CABA | 10% owner | Form 4 sale | 295,000 | $3.8M | 47.0% | Unusual | SEC |
| Sep 7, 2021 | Sep 9, 2021 | 5AM Ventures V, L.P. | CABA | 10% owner | Form 4 sale | 625,000 | $6.1M | 23.9% | Plan not stated | SEC |
| Jan 12, 2021 | Jan 12, 2021 | Rocklage Scott M | CABA | 10% owner | Form 4 sale | 387,000 | $5M | 51.1% | Unusual | SEC |
| Dec 10, 2020 | Dec 14, 2020 | Schwab Andrew J. | CABA | 10% owner | Form 4 sale | 298,000 | $4.4M | 41.6% | Unusual | SEC |